SCHEMBL2913786

SCHEMBL2913786

COc1c(Br)cc(-n2c(=O)cc[nH]c2=O)cc1/C=C/c1ccc(NS(C)(=O)=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.47
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33
TUBA1B P68363 2/20 0.33
TUBA4A P68366 2/20 0.33
TUBB4B P68371 2/20 0.33
TUBB3 Q13509 2/20 0.33
TUBB2A Q13885 2/20 0.33
TUBB8 Q3ZCM7 2/20 0.33
TUBA3E Q6PEY2 2/20 0.33
TUBA1A Q71U36 2/20 0.33
TUBA1C Q9BQE3 2/20 0.33
TUBB6 Q9BUF5 2/20 0.33
TUBB2B Q9BVA1 2/20 0.33
TUBB1 Q9H4B7 2/20 0.33
KDM1A O60341 1/20 0.32
HDAC4 P56524 2/20 0.32
HDAC1 Q13547 2/20 0.32
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915016 0.89 CYP3A4 (0.47) CYP3A4PTGS2CRBNTEAD2FLT3
SCHEMBL2915424 0.89 CYP3A4 (0.49) CYP3A4PTGS2CRBNTEAD2FLT3
SCHEMBL479100 0.87 CYP3A4 (0.61) CYP3A4PTGS2CRBN
Water SCHEMBL2484221 0.86 CYP3A4 (0.60) CYP3A4PTGS2CRBN
Water SCHEMBL2908232 0.86 CYP3A4 (0.59) CYP3A4CRBN
SCHEMBL2914308 0.84 CYP3A4 (0.47) CYP3A4CRBN
SCHEMBL2913043 0.84 CYP3A4 (0.51) CYP3A4PTGS2CRBN
SCHEMBL2913615 0.83 CYP3A4 (0.46) CYP3A4HDAC1CRBN
SCHEMBL2912679 0.83 CYP3A4 (0.46) CYP3A4CRBN
SCHEMBL2910162 0.83 CYP3A4 (0.46) CYP3A4CRBNPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
EP-2203430-A1 N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS Abbott Laboratories (US) 2010-07-07 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed
WO-2009039135-A1 N-PHENYL-DIOXO-HYDROPYRIMIDINES USEFUL AS HEPATITIS C VIRUS (HCV) INHIBITORS ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed